Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

Achterrath-Tuckermann, U; Simmet, T; Luck, W; Szelenyi, I; Peskar, BA.
Inhibition of cysteinyl-leukotriene production by azelastine and its biological significance.
Agents Actions. 1988; 24(3-4):217-223 Doi: 10.1007/BF02028274
Web of Science PubMed FullText FullText_MUG Google Scholar

Co-authors Med Uni Graz: Peskar Bernhard
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Azelastine is a phthalazinone derivative with a wide spectrum of pharmacological activities. Actively sensitized guinea pigs were used to examine the broncholytic effect of azelastine in vivo. Furthermore, the influence of azelastine on the production of arachidonic acid (AA) metabolites was investigated in vitro and compared to the effects of nordihydroguaiaretic acid (NDGA), indomethacin and ketotifen. In vivo, azelastine protected actively sensitized guinea-pigs against ovalbumin-induced bronchospasm with an ID50 of 0.08 mg/kg orally. Ketotifen was similarly active (ID50 = 0.05 mg/kg). Antigen-induced contraction of isolated tracheal rings of sensitized guinea-pigs was concentration-dependently inhibited by azelastine and NDGA with IC50-values of 94.1 and 34.2 mumol/l, respectively. Ketotifen exerted only weak inhibitory activity (18% at 100 mumol/l). The arachidonic acid-induced contraction of isolated guinea-pig tracheal rings was also inhibited both by azelastine (IC50 = 92.6 mumol/l) and NDGA (IC50 = 20.4 mumol/l). Ketotifen was inactive on this model. Antigen challenge of chopped lung tissue from sensitized guinea-pigs resulted in the release of cysteinyl-leukotrienes (LT) which were identified by reversed phase high pressure liquid chromatography (HPLC) as LTD4 and LTE4. The release of cysteinyl-LT from sensitized guinea-pig lung tissue induced by antigen challenge was concentration-dependently inhibited by azelastine (IC50 = 35.2 mumol/l) and NDGA (IC50 = 8.4 mumol/l) but not by ketotifen and indomethacin. By contrast, indomethacin caused a pronounced augmentation of cysteinyl-LT release. The concentration of indomethacin, which augmented cysteinyl-LT release by 50% was 0.19 mumol/l.(ABSTRACT TRUNCATED AT 250 WORDS)
Find related publications in this database (using NLM MeSH Indexing): Animals -; Antigens - immunology; Arachidonic Acid - immunology; Arachidonic Acids - metabolism; Bronchi - drug effects; Guinea Pigs - drug effects; Histamine H1 Antagonists - pharmacology; Indomethacin - pharmacology; Ketotifen - pharmacology; Leukotriene E4 - pharmacology; Male - pharmacology; Muscle Contraction - drug effects; Nordihydroguaiaretic Acid - pharmacology; Ovalbumin - antagonists and inhibitors; Phthalazines - pharmacology; Pyridazines - pharmacology; SRS-A - analogs and derivatives; Thromboxane B2 - metabolism; Trachea - drug effects